200 related articles for article (PubMed ID: 17575147)
1. Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.
Challita-Eid PM; Morrison K; Etessami S; An Z; Morrison KJ; Perez-Villar JJ; Raitano AB; Jia XC; Gudas JM; Kanner SB; Jakobovits A
Cancer Res; 2007 Jun; 67(12):5798-805. PubMed ID: 17575147
[TBL] [Abstract][Full Text] [Related]
2. Six-transmembrane epithelial antigen of the prostate-1 plays a role for in vivo tumor growth via intercellular communication.
Yamamoto T; Tamura Y; Kobayashi J; Kamiguchi K; Hirohashi Y; Miyazaki A; Torigoe T; Asanuma H; Hiratsuka H; Sato N
Exp Cell Res; 2013 Oct; 319(17):2617-26. PubMed ID: 23916873
[TBL] [Abstract][Full Text] [Related]
3. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
[TBL] [Abstract][Full Text] [Related]
4. Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.
Kobayashi H; Nagato T; Sato K; Aoki N; Kimura S; Murakami M; Iizuka H; Azumi M; Kakizaki H; Tateno M; Celis E
Cancer Res; 2007 Jun; 67(11):5498-504. PubMed ID: 17545632
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
Goya M; Miyamoto S; Nagai K; Ohki Y; Nakamura K; Shitara K; Maeda H; Sangai T; Kodama K; Endoh Y; Ishii G; Hasebe T; Yonou H; Hatano T; Ogawa Y; Ochiai A
Cancer Res; 2004 Sep; 64(17):6252-8. PubMed ID: 15342412
[TBL] [Abstract][Full Text] [Related]
6. Targeting tomoregulin for radioimmunotherapy of prostate cancer.
Zhao XY; Schneider D; Biroc SL; Parry R; Alicke B; Toy P; Xuan JA; Sakamoto C; Wada K; Schulze M; Müller-Tiemann B; Parry G; Dinter H
Cancer Res; 2005 Apr; 65(7):2846-53. PubMed ID: 15805286
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of six-transmembrane epithelial antigen of the prostate expressed in prostatic carcinoma].
Li L; Li J; Shen Z; Liu W; Chen Z
Zhonghua Nan Ke Xue; 2004 May; 10(5):351-4. PubMed ID: 15190827
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer.
Garcia-Hernandez Mde L; Gray A; Hubby B; Kast WM
Cancer Res; 2007 Feb; 67(3):1344-51. PubMed ID: 17283172
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Intercellular Communication between Prostate Cancer Cells by A Specific Anti-STEAP-1 Single Chain Antibody.
Esmaeili SA; Nejatollahi F; Sahebkar A
Anticancer Agents Med Chem; 2018; 18(12):1674-1679. PubMed ID: 29219059
[TBL] [Abstract][Full Text] [Related]
11. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth.
Zhang Y; Ran Y; Yu L; Hu H; Zhou Z; Sun L; Lou J; Yang Z
Anticancer Res; 2006; 26(4B):2963-70. PubMed ID: 16886621
[TBL] [Abstract][Full Text] [Related]
14. Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.
Kinoshita Y; Kuratsukuri K; Newman N; Rovito PM; Kaumaya PT; Wang CY; Haas GP
Prostate Cancer Prostatic Dis; 2005; 8(4):359-63. PubMed ID: 16172607
[TBL] [Abstract][Full Text] [Related]
15. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
Xuan JA; Schneider D; Toy P; Lin R; Newton A; Zhu Y; Finster S; Vogel D; Mintzer B; Dinter H; Light D; Parry R; Polokoff M; Whitlow M; Wu Q; Parry G
Cancer Res; 2006 Apr; 66(7):3611-9. PubMed ID: 16585186
[TBL] [Abstract][Full Text] [Related]
16. ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy.
Ben-Yosef R; Starr A; Karaush V; Loew V; Lev-Ari S; Barnea I; Lidawi G; Shtabsky A; Greif Y; Yarden Y; Vexler A
Prostate; 2007 Jun; 67(8):871-80. PubMed ID: 17440944
[TBL] [Abstract][Full Text] [Related]
17. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells.
Russell MR; Jamieson WL; Dolloff NG; Fatatis A
Oncogene; 2009 Jan; 28(3):412-21. PubMed ID: 18850002
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody.
Perk J; Gil-Bazo I; Chin Y; de Candia P; Chen JJ; Zhao Y; Chao S; Cheong W; Ke Y; Al-Ahmadie H; Gerald WL; Brogi E; Benezra R
Cancer Res; 2006 Nov; 66(22):10870-7. PubMed ID: 17108123
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
Gu Y; Li H; Miki J; Kim KH; Furusato B; Sesterhenn IA; Chu WS; McLeod DG; Srivastava S; Ewing CM; Isaacs WB; Rhim JS
Exp Cell Res; 2006 Apr; 312(6):831-43. PubMed ID: 16413016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]